Insider

Procter & Gamble executives report stock sales

Procter & Gamble Co. officials filed reports of stock sales on November 5 and November 12, 2026. Andre Schulten and Juliana Monteiro Santos de Azevedo completed transactions on November 5, while Hesham Abd El Hak completed his on November 12. These transactions change the officers' direct equity stakes but do not affect the company's operating or financial results.

Verified against 4 archived primary sources · SHA-256 recorded Inspect sources & citations ↓
A grocery store aisle with shelves stocked with cereal boxes and milk cartons
Photo by Nathália Rosa on Unsplash
30,677
Shares sold by CFO
$5,184,413
Value of shares sold

Key points

  • Chief financial officer Andre Schulten exercised derivative securities on November 5, 2026, acquiring 30,677 shares, and simultaneously sold the same number of shares on the open market.
  • Juliana Monteiro Santos de Azevedo, CEO of Grooming, sold 5,370 shares for $907,530 on November 5, 2026.
  • All reported transactions were open-market sales.

Chief financial officer transactions

Chief financial officer Andre Schulten exercised derivative securities on November 5, 2026, acquiring 30,677 shares, and simultaneously sold the same number of shares on the open market. The total value of the shares sold was $5,184,413.

Insider stock sales in November 2026

Andre Schulten$5,184,413Juliana Monteiro Santos de Azevedo$907,530Hesham Abd El Hak$379,057.5
Data from the original sources listed alongside.

Other insider transactions

Juliana Monteiro Santos de Azevedo, CEO of Grooming, sold 5,370 shares for $907,530 on November 5, 2026.

Hesham Abd El Hak, CEO of Baby and Feminine Care, sold 2,250 shares for $379,057.5 on November 12, 2026. This transaction followed a Form 144 notice of a proposed sale filed on November 9, 2026, which stated the intention to sell that amount of shares.

Ownership structure

All reported transactions were open-market sales. These filings confirm a reduction in the number of shares held by the executives following each sale.

No information on trading plans

The forms filed by the executives did not indicate the use of a pre-arranged trading plan, a document that sets a schedule and conditions for selling shares. While this notation alone does not prove the presence or absence of a plan, the specific reasons and personal financial strategies behind each decision remain undisclosed.

What to watch

Shareholders should monitor subsequent official filings on the Securities and Exchange Commission (SEC) website to track changes in beneficial ownership and new stock transactions.

Original sources

  1. 4 filing, November 9, 2026November 9, 2026SHA-256 of our archived copy 7a6a6654abbc…
  2. 4 filing, November 9, 2026November 9, 2026SHA-256 of our archived copy 62aace8d02b6…
  3. 144 filing, November 9, 2026November 9, 2026SHA-256 of our archived copy c315371bdd32…
  4. 4 filing, November 12, 2026November 12, 2026SHA-256 of our archived copy ac59bfde2c2e…
Cite this article

The fingerprint identifies the exact version of each original that the article was written from; the original stays at its source.

Prepared by AI from official company documents; automatic checks and an AI editor review it before publication, and not every article is read by a person. This is not investment advice. Editorial standards